BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sanchez-Rodriguez E, Egea-Zorrilla A, Plaza-Díaz J, Aragón-Vela J, Muñoz-Quezada S, Tercedor-Sánchez L, Abadia-Molina F. The Gut Microbiota and Its Implication in the Development of Atherosclerosis and Related Cardiovascular Diseases. Nutrients 2020;12:E605. [PMID: 32110880 DOI: 10.3390/nu12030605] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 16.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang F, Zhao C, Yang M, Zhang L, Wei R, Meng K, Bao Y, Zhang L, Zheng J. Four Citrus Flavanones Exert Atherosclerosis Alleviation Effects in ApoE-/- Mice via Different Metabolic and Signaling Pathways. J Agric Food Chem 2021;69:5226-37. [PMID: 33890787 DOI: 10.1021/acs.jafc.1c01463] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Anesi A, Berding K, Clarke G, Stanton C, Cryan JF, Caplice N, Ross RP, Doolan A, Vrhovsek U, Mattivi F. Metabolomic Workflow for the Accurate and High-Throughput Exploration of the Pathways of Tryptophan, Tyrosine, Phenylalanine, and Branched-Chain Amino Acids in Human Biofluids. J Proteome Res 2022. [PMID: 35380444 DOI: 10.1021/acs.jproteome.1c00946] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Chowdhury MR, Mas-ud MA, Ali MR, Fatamatuzzohora M, Shimu AS, Haq MA, Islam MA, Hossain MF, Hosenuzzaman M, Islam MM, Hasan MF, Matin MN. Harmful Effects of COVID-19 on Major Human Body Organs: A Review. J Pure Appl Microbiol 2021;15:500-11. [DOI: 10.22207/jpam.15.2.14] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Wang Z, Peters BA, Usyk M, Xing J, Hanna DB, Wang T, Post WS, Landay AL, Hodis HN, Weber K, French A, Golub ET, Lazar J, Gustafson D, Kassaye S, Aouizerat B, Haberlen S, Malvestutto C, Budoff M, Wolinsky SM, Sharma A, Anastos K, Clish CB, Kaplan RC, Burk RD, Qi Q. Gut Microbiota, Plasma Metabolomic Profiles, and Carotid Artery Atherosclerosis in HIV Infection. Arterioscler Thromb Vasc Biol 2022;42:1081-93. [PMID: 35678187 DOI: 10.1161/ATVBAHA.121.317276] [Reference Citation Analysis]
5 Choroszy M, Sobieszczańska B, Litwinowicz K, Łaczmański Ł, Chmielarz M, Walczuk U, Roleder T, Radziejewska J, Wawrzyńska M. Co-toxicity of Endotoxin and Indoxyl Sulfate, Gut-Derived Bacterial Metabolites, to Vascular Endothelial Cells in Coronary Arterial Disease Accompanied by Gut Dysbiosis. Nutrients 2022;14:424. [PMID: 35276782 DOI: 10.3390/nu14030424] [Reference Citation Analysis]
6 Huang K, Wang Y, Bai Y, Luo Q, Lin X, Yang Q, Wang S, Xin H. Gut Microbiota and Metabolites in Atrial Fibrillation Patients and Their Changes after Catheter Ablation. Microbiol Spectr 2022;:e0107721. [PMID: 35384710 DOI: 10.1128/spectrum.01077-21] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Lei Z, Yang Y, Liu S, Lei Y, Yang L, Zhang X, Liu W, Wu H, Yang C, Guo J. Dihydroartemisinin ameliorates dextran sulfate sodium induced inflammatory bowel diseases in mice. Bioorg Chem 2020;100:103915. [PMID: 32450383 DOI: 10.1016/j.bioorg.2020.103915] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Plaza-Díaz J, Solís-Urra P, Rodríguez-Rodríguez F, Olivares-Arancibia J, Navarro-Oliveros M, Abadía-Molina F, Álvarez-Mercado AI. The Gut Barrier, Intestinal Microbiota, and Liver Disease: Molecular Mechanisms and Strategies to Manage. Int J Mol Sci 2020;21:E8351. [PMID: 33171747 DOI: 10.3390/ijms21218351] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
9 Xiang D, Liu Y, Zhou S, Zhou E, Wang Y. Protective Effects of Estrogen on Cardiovascular Disease Mediated by Oxidative Stress. Oxid Med Cell Longev 2021;2021:5523516. [PMID: 34257804 DOI: 10.1155/2021/5523516] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Sun W, Du D, Fu T, Han Y, Li P, Ju H. Alterations of the Gut Microbiota in Patients With Severe Chronic Heart Failure. Front Microbiol 2021;12:813289. [PMID: 35173696 DOI: 10.3389/fmicb.2021.813289] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Qi YZ, Yang XS, Jiang YH, Shao LL, Jiang LY, Yang CH. Study of the Mechanism Underlying the Antihypertensive Effects of Eucommia ulmoides and Tribulus terrestris Based on an Analysis of the Intestinal Microbiota and Metabonomics. Biomed Res Int 2020;2020:4261485. [PMID: 33204695 DOI: 10.1155/2020/4261485] [Reference Citation Analysis]
12 Gawlik-Kotelnicka O, Skowrońska A, Margulska A, Czarnecka-Chrebelska KH, Łoniewski I, Skonieczna-Żydecka K, Strzelecki D. The Influence of Probiotic Supplementation on Depressive Symptoms, Inflammation, and Oxidative Stress Parameters and Fecal Microbiota in Patients with Depression Depending on Metabolic Syndrome Comorbidity-PRO-DEMET Randomized Study Protocol. J Clin Med 2021;10:1342. [PMID: 33804999 DOI: 10.3390/jcm10071342] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Jung E, Romero R, Yeo L, Gomez-Lopez N, Chaemsaithong P, Jaovisidha A, Gotsch F, Erez O. The etiology of preeclampsia. Am J Obstet Gynecol 2022;226:S844-66. [PMID: 35177222 DOI: 10.1016/j.ajog.2021.11.1356] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
14 Maffei S, Forini F, Canale P, Nicolini G, Guiducci L. Gut Microbiota and Sex Hormones: Crosstalking Players in Cardiometabolic and Cardiovascular Disease. IJMS 2022;23:7154. [DOI: 10.3390/ijms23137154] [Reference Citation Analysis]
15 Niederseer D, Wernly B, Aigner E, Stickel F, Datz C. NAFLD and Cardiovascular Diseases: Epidemiological, Mechanistic and Therapeutic Considerations. J Clin Med 2021;10:467. [PMID: 33530440 DOI: 10.3390/jcm10030467] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Chen Y, Zhou J, Wang L. Role and Mechanism of Gut Microbiota in Human Disease. Front Cell Infect Microbiol 2021;11:625913. [PMID: 33816335 DOI: 10.3389/fcimb.2021.625913] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
17 Li Q, Gao B, Siqin B, He Q, Zhang R, Meng X, Zhang N, Zhang N, Li M. Gut Microbiota: A Novel Regulator of Cardiovascular Disease and Key Factor in the Therapeutic Effects of Flavonoids. Front Pharmacol 2021;12:651926. [PMID: 34220497 DOI: 10.3389/fphar.2021.651926] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Arun KB, Madhavan A, Sindhu R, Emmanual S, Binod P, Pugazhendhi A, Sirohi R, Reshmy R, Awasthi MK, Gnansounou E, Pandey A. Probiotics and gut microbiome - Prospects and challenges in remediating heavy metal toxicity. J Hazard Mater 2021;420:126676. [PMID: 34329091 DOI: 10.1016/j.jhazmat.2021.126676] [Reference Citation Analysis]
19 John A, Yang H, Muhammad S, Khan ZI, Yu H, Luqman M, Tofail M, Hussain MI, Awan MUF. Cross Talk between Synthetic Food Colors (Azo Dyes), Oral Flora, and Cardiovascular Disorders. Applied Sciences 2022;12:7084. [DOI: 10.3390/app12147084] [Reference Citation Analysis]
20 Plaza-Diaz J. Nutrition, Microbiota and Noncommunicable Diseases. Nutrients 2020;12:E1971. [PMID: 32630712 DOI: 10.3390/nu12071971] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Badran M, Mashaqi S, Gozal D. The gut microbiome as a target for adjuvant therapy in obstructive sleep apnea. Expert Opin Ther Targets 2020;24:1263-82. [PMID: 33180654 DOI: 10.1080/14728222.2020.1841749] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Plaza-Díaz J, Solis-Urra P, Aragón-Vela J, Rodríguez-Rodríguez F, Olivares-Arancibia J, Álvarez-Mercado AI. Insights into the Impact of Microbiota in the Treatment of NAFLD/NASH and Its Potential as a Biomarker for Prognosis and Diagnosis. Biomedicines 2021;9:145. [PMID: 33546191 DOI: 10.3390/biomedicines9020145] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Lapidot Y, Reshef L, Goldsmith R, Na'amnih W, Kassem E, Ornoy A, Gophna U, Muhsen K. The Associations between Diet and Socioeconomic Disparities and the Intestinal Microbiome in Preadolescence. Nutrients 2021;13:2645. [PMID: 34444813 DOI: 10.3390/nu13082645] [Reference Citation Analysis]
24 Nelson JW, Phillips SC, Ganesh BP, Petrosino JF, Durgan DJ, Bryan RM. The gut microbiome contributes to blood-brain barrier disruption in spontaneously hypertensive stroke prone rats. FASEB J 2021;35:e21201. [PMID: 33496989 DOI: 10.1096/fj.202001117R] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Yan N, Wang L, Li Y, Wang T, Yang L, Yan R, Wang H, Jia S. Metformin intervention ameliorates AS in ApoE-/- mice through restoring gut dysbiosis and anti-inflammation. PLoS One 2021;16:e0254321. [PMID: 34264978 DOI: 10.1371/journal.pone.0254321] [Reference Citation Analysis]
26 Rebelo JS, Domingues CPF, Dionisio F, Gomes MC, Botelho A, Nogueira T. COVID-19 Lockdowns May Reduce Resistance Genes Diversity in the Human Microbiome and the Need for Antibiotics. Int J Mol Sci 2021;22:6891. [PMID: 34206965 DOI: 10.3390/ijms22136891] [Reference Citation Analysis]
27 Li H, Christman LM, Li R, Gu L. Synergic interactions between polyphenols and gut microbiota in mitigating inflammatory bowel diseases. Food Funct 2020;11:4878-91. [PMID: 32490857 DOI: 10.1039/d0fo00713g] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
28 Soto Chervin C, Gajewski T. Microbiome-based interventions: therapeutic strategies in cancer immunotherapy. Immuno-Oncology Technology 2020;8:12-20. [DOI: 10.1016/j.iotech.2020.11.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Pitz Jacobsen D, Fjeldstad HE, Johnsen GM, Fosheim IK, Moe K, Alnæs-Katjavivi P, Dechend R, Sugulle M, Staff AC. Acute Atherosis Lesions at the Fetal-Maternal Border: Current Knowledge and Implications for Maternal Cardiovascular Health. Front Immunol 2021;12:791606. [PMID: 34970270 DOI: 10.3389/fimmu.2021.791606] [Reference Citation Analysis]
30 Viana SD, Nunes S, Reis F. ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities - Role of gut microbiota dysbiosis. Ageing Res Rev 2020;62:101123. [PMID: 32683039 DOI: 10.1016/j.arr.2020.101123] [Cited by in Crossref: 69] [Cited by in F6Publishing: 55] [Article Influence: 34.5] [Reference Citation Analysis]
31 Forlano R, Mullish BH, Roberts LA, Thursz MR, Manousou P. The Intestinal Barrier and Its Dysfunction in Patients with Metabolic Diseases and Non-Alcoholic Fatty Liver Disease. Int J Mol Sci 2022;23:662. [PMID: 35054847 DOI: 10.3390/ijms23020662] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Vignesh R, Swathirajan CR, Tun ZH, Rameshkumar MR, Solomon SS, Balakrishnan P. Could Perturbation of Gut Microbiota Possibly Exacerbate the Severity of COVID-19 via Cytokine Storm? Front Immunol 2020;11:607734. [PMID: 33569053 DOI: 10.3389/fimmu.2020.607734] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
33 Cao RY, Zhang Y, Feng Z, Liu S, Liu Y, Zheng H, Yang J. The Effective Role of Natural Product Berberine in Modulating Oxidative Stress and Inflammation Related Atherosclerosis: Novel Insights Into the Gut-Heart Axis Evidenced by Genetic Sequencing Analysis. Front Pharmacol 2021;12:764994. [PMID: 35002703 DOI: 10.3389/fphar.2021.764994] [Reference Citation Analysis]
34 Chen W, Zhang S, Wu J, Ye T, Wang S, Wang P, Xing D. Butyrate-producing bacteria and the gut-heart axis in atherosclerosis. Clin Chim Acta 2020;507:236-41. [PMID: 32376324 DOI: 10.1016/j.cca.2020.04.037] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
35 Wu G, Chen L, Gu Y, Hong Y, Ma J, Zheng N, Zhong J, Liu AJ, Sheng L, Zhang W, Li H. Exploring the mechanism underlying the cardioprotective effect of shexiang baoxin pill on acute myocardial infarction rats by comprehensive metabolomics. J Ethnopharmacol 2020;259:113001. [PMID: 32464316 DOI: 10.1016/j.jep.2020.113001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
36 Ferreira C, Viana SD, Reis F. Is Gut Microbiota Dysbiosis a Predictor of Increased Susceptibility to Poor Outcome of COVID-19 Patients? An Update. Microorganisms 2020;9:E53. [PMID: 33379162 DOI: 10.3390/microorganisms9010053] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
37 Vilne B, Ķibilds J, Siksna I, Lazda I, Valciņa O, Krūmiņa A. Could Artificial Intelligence/Machine Learning and Inclusion of Diet-Gut Microbiome Interactions Improve Disease Risk Prediction? Case Study: Coronary Artery Disease. Front Microbiol 2022;13:627892. [DOI: 10.3389/fmicb.2022.627892] [Reference Citation Analysis]
38 Piccioni A, de Cunzo T, Valletta F, Covino M, Rinninella E, Raoul P, Zanza C, Mele MC, Franceschi F. Gut Microbiota and Environment in Coronary Artery Disease. Int J Environ Res Public Health 2021;18:4242. [PMID: 33923612 DOI: 10.3390/ijerph18084242] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Fang C, Zuo K, Zhang W, Zhong J, Li J, Xu L, Yang X, Scicchitano P. Association between Gut Microbiota Dysbiosis and the CHA2DS2-VASc Score in Atrial Fibrillation Patients. International Journal of Clinical Practice 2022;2022:1-10. [DOI: 10.1155/2022/7942605] [Reference Citation Analysis]
40 Kibel A, Lukinac AM, Dambic V, Juric I, Selthofer-Relatic K. Oxidative Stress in Ischemic Heart Disease. Oxid Med Cell Longev 2020;2020:6627144. [PMID: 33456670 DOI: 10.1155/2020/6627144] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
41 Vignesh R, Velu V, Sureban SM. Could Nutraceutical Approaches Possibly Attenuate the Cytokine Storm in COVID-19 Patients? Front Cell Infect Microbiol 2021;11:667733. [PMID: 33968808 DOI: 10.3389/fcimb.2021.667733] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Wang F, Zhao C, Tian G, Wei X, Ma Z, Cui J, Wei R, Bao Y, Kong W, Zheng J. Naringin Alleviates Atherosclerosis in ApoE –/– Mice by Regulating Cholesterol Metabolism Involved in Gut Microbiota Remodeling. J Agric Food Chem 2020;68:12651-60. [DOI: 10.1021/acs.jafc.0c05800] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
43 Zhao M, Pi Y, Zhang L, Che H. Knowledge Discovery-Based Analysis of Health Factors of Urinary Infections in Elderly Cardiology Inpatients. Journal of Healthcare Engineering 2022;2022:1-8. [DOI: 10.1155/2022/7037037] [Reference Citation Analysis]
44 Oynotkinova OS, Nikonov EL, Demidova TY, Baranov AP, Kryukov EV, Dedov EI, Karavashkina EA. [Changes in the intestinal microbiota as a risk factor for dyslipidemia, atherosclerosis and the role of probiotics in their prevention]. Ter Arkh 2020;92:94-101. [PMID: 33346437 DOI: 10.26442/00403660.2020.09.000784] [Reference Citation Analysis]
45 Xu S, Zhang X, Liu S, Feng S, Xiang G, Xu C, Fan Z, Xu K, Wang N, Wang Y, Che J, Liu Z, Mu Y, Li K. Multi-Omic Analysis in a Metabolic Syndrome Porcine Model Implicates Arachidonic Acid Metabolism Disorder as a Risk Factor for Atherosclerosis. Front Nutr 2022;9:807118. [DOI: 10.3389/fnut.2022.807118] [Reference Citation Analysis]
46 Koszewicz M, Jaroch J, Brzecka A, Ejma M, Budrewicz S, Mikhaleva LM, Muresanu C, Schield P, Somasundaram SG, Kirkland CE, Avila-Rodriguez M, Aliev G. Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment. Pharmacol Res 2021;164:105277. [PMID: 33166735 DOI: 10.1016/j.phrs.2020.105277] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
47 Künstner A, Aherrahrou R, Hirose M, Bruse P, Ibrahim SM, Busch H, Erdmann J, Aherrahrou Z. Effect of Differences in the Microbiome of Cyp17a1-Deficient Mice on Atherosclerotic Background. Cells 2021;10:1292. [PMID: 34070975 DOI: 10.3390/cells10061292] [Reference Citation Analysis]